Biomet Completes $1 Billion Notes Offering and Amended Credit Facility
Date: 08/08/12Cahill represented the joint book-running managers and co-managers in the Rule 144A/Reg S offering of $1,000,000,000 6.5% Senior Notes due 2020 by Biomet, Inc., a leading orthopedic medical device company. Proceeds from the offering will be used to refinance existing indebtedness. Cahill also represented the dealer managers in connection with Biomet, Inc.’s tender offer for its outstanding 10 3/8% / 11 1/8% Senior Toggle Notes due 2017.
Cahill also represented Bank of America as administrative agent and Merrill Lynch, Pierce, Fenner & Smith Inc. and Citigroup Global Markets as lead arrangers in connection with the amendment and restatement of Biomet, Inc.’s cash flow credit facility that extended the maturity of the revolving credit commitments and a portion of the outstanding term loans.